Zhao GY - Search Results

Year	Number of Results
1980	1
1981	1
1982	1
1984	1
1987	2
1988	2
1992	1
1994	1
1995	2
1999	1
2000	2
2002	3
2003	1
2004	3
2005	5
2006	6
2007	5
2008	8
2009	5
2010	6
2011	7
2012	9
2013	11
2014	14
2015	12
2016	11
2017	10
2018	7
2019	7
2020	6
2021	17
2022	13
2023	6
2024	16
2025	5

1

Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer.

Zhou L, Yang XQ, Zhao GY, Wang FJ, Liu X. Zhou L, et al. Among authors: zhao gy. Front Immunol. 2023 Jan 27;14:1044353. doi: 10.3389/fimmu.2023.1044353. eCollection 2023. Front Immunol. 2023. PMID: 36776899 Free PMC article.

2

Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential.

Xl L, Gy Z, R G, N C. Xl L, et al. Among authors: gy z. Front Immunol. 2022 Aug 5;13:956361. doi: 10.3389/fimmu.2022.956361. eCollection 2022. Front Immunol. 2022. PMID: 35990689 Free PMC article. Review.

3

Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.

Zhu YQ, Huang Y, Shi YH, Huang CS, Zhao GY, Liu ZD, Ma MJ, Ye JY, Xu X, Liu Q, Huang XT, Wang JQ, Xu QC, Yin XY. Zhu YQ, et al. Among authors: zhao gy. Adv Sci (Weinh). 2024 Dec;11(47):e2406714. doi: 10.1002/advs.202406714. Epub 2024 Nov 3. Adv Sci (Weinh). 2024. PMID: 39488785 Free PMC article.

4

Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism.

Shi YH, Liu ZD, Ma MJ, Zhao GY, Zhu YQ, Wang JQ, Yu YY, Huang XT, Ye JY, Li FX, Wang XY, Xu QC, Yin XY. Shi YH, et al. Among authors: zhao gy. Adv Sci (Weinh). 2024 Oct;11(40):e2407069. doi: 10.1002/advs.202407069. Epub 2024 Sep 3. Adv Sci (Weinh). 2024. PMID: 39225567 Free PMC article.

5

N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance.

Ma MJ, Shi YH, Liu ZD, Zhu YQ, Zhao GY, Ye JY, Li FX, Huang XT, Wang XY, Wang JQ, Xu QC, Yin XY. Ma MJ, et al. Among authors: zhao gy. Oncogene. 2024 Jul;43(31):2405-2420. doi: 10.1038/s41388-024-03092-3. Epub 2024 Jun 24. Oncogene. 2024. PMID: 38914663 Free PMC article.

6

The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.

Wang LY, Yu B, Peng Y, Mou K, Zhan Y, Wang YM, Ji W, Xu C, Xiao LD, Chen Y, Wang H, She ZH, Dai P, Zhao GY, Wang Y, Yu LL, Yu M, Liu K, Cui JJ, Liu R, Li X, Huang YF, Liu ZQ, Ouyang DS, Zhang W, Li Q, Xiong XL, Guo CX, Li JG, Lv QL, Xing QH, Wang HJ, Li ZL, Wu JC, Huang LJ, He J, Tan LM, Hong WX, Wang XC, Li CP, Lu Q, Zhang L, Kong XD, Zhou HH, Yin JY. Wang LY, et al. Among authors: zhao gy. Innovation (Camb). 2025 Jan 18;6(2):100773. doi: 10.1016/j.xinn.2024.100773. eCollection 2025 Feb 3. Innovation (Camb). 2025. PMID: 39991480 Free PMC article.

7

CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy.

Liu ZD, Shi YH, Xu QC, Zhao GY, Zhu YQ, Li FX, Ma MJ, Ye JY, Huang XT, Wang XY, Xu X, Wang JQ, Zhao W, Yin XY. Liu ZD, et al. Among authors: zhao gy. Cancer Lett. 2024 Mar 31;585:216640. doi: 10.1016/j.canlet.2024.216640. Epub 2024 Jan 28. Cancer Lett. 2024. PMID: 38290659 Free article.

8

ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing manner.

Liu Q, Huang CS, Chen S, Zhu YQ, Huang XT, Zhao GY, Xu QC, Shi YH, Li W, Wang R, Yin XY. Liu Q, et al. Among authors: zhao gy. Cell Prolif. 2024 Oct;57(10):e13659. doi: 10.1111/cpr.13659. Epub 2024 May 21. Cell Prolif. 2024. PMID: 38773866 Free PMC article.

9

Studies of SARS virus vaccines.

Zheng BJ, Du LY, Zhao GY, Lin YP, Sui HY, Chan C, Ma S, Guan Y, Yuen KY. Zheng BJ, et al. Among authors: zhao gy. Hong Kong Med J. 2008 Aug;14 Suppl 4:39-43. Hong Kong Med J. 2008. PMID: 18708674 Free article. Review.

10

The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review.

Cui HX, Yang XQ, Zhao GY, Wang FJ, Liu X. Cui HX, et al. Among authors: zhao gy. Front Immunol. 2025 May 1;16:1540751. doi: 10.3389/fimmu.2025.1540751. eCollection 2025. Front Immunol. 2025. PMID: 40376001 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Results by year